Trademark: 98253894
Word
GRATICULE
Status
Pending
Status Code
681
Status Date
Wednesday, June 19, 2024
Serial Number
98253894
Mark Type
3
Filing Date
Friday, November 3, 2023
Published for Opposition
Tuesday, July 23, 2024

Trademark Owner History

Classifications
35 Business consulting services; Consulting services in the field of patient relationship management for healthcare providers; Data processing services in the field of healthcare, namely, curation, de-identification, and enrichment of healthcare, medical, clinical, and patient data; Recruitment and placement of volunteers in the field of clinical studies, namely, recruiting and placing patients for participation in clinical studies for the testing of drugs, testing of medical devices, and diagnostic research; Business data analysis services in the field of healthcare, medical, clinical, and patient data; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Collecting and analyzing claims data from healthcare organizations for business purposes; Commercial administration of the licensing of healthcare, biotechnology, and clinical data of others; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
44 Consulting services in the field of healthcare; Health care services, namely, providing a database featuring information in the field of health, in particular, patient information in the field of neurology, cardiology, oncology and rare diseases information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of medical data for medical diagnosis and treatment
42 Innovation consulting services, namely, advising others in the areas of product development; Platform as a service (PAAS) featuring computer software platforms for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; Platform as a service (PAAS) featuring computer software platforms for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; Platform as a service (PAAS) featuring computer software platforms for providing access to an electronic exchange of medical records across a nationwide health information network; Software as a service (SAAS) services featuring software for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; Software as a service (SAAS) services featuring software for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; Software as a service (SAAS) services featuring software for providing access to an electronic exchange of medical records across a nationwide health information network; Compiling data for research purposes in the field of medical science and medical consultancy; Providing an on-line searchable database in the field of healthcare data, biotechnology data as it relates to healthcare, medical data, clinical data, and patient data, all for scientific research purposes
The mark consists of a square comprising sixteen smaller squares arranged in a diagonal gradient grid from one dark blue square in the upper left corner to two light blue squares in the next diagonal to three pale blue squares in the next diagonal to four pale green squares in the next diagonal to three light green squares in the next diagonal to two green squares in the next diagonal to one dark green square in the lower right corner, all of which is next to the blue text "GRATICULE" in a lowercase font.
The color(s) blue, light blue, pale blue, pale green, light green, green, and dark green is/are claimed as a feature of the mark.

Trademark Events
Nov 3, 2023
New Application Entered
Jan 23, 2024
New Application Office Supplied Data Entered
Jan 24, 2024
Notice Of Design Search Code E-Mailed
Jun 13, 2024
Assigned To Examiner
Jun 17, 2024
Notification Of Non-Final Action E-Mailed
Jun 17, 2024
Non-Final Action E-Mailed
Jun 17, 2024
Non-Final Action Written
Jun 18, 2024
Examiner's Amendment Entered
Jun 18, 2024
Notification Of Examiners Amendment E-Mailed
Jun 18, 2024
Examiner's Amendment Entered
Jun 18, 2024
Examiners Amendment -Written
Jun 18, 2024
Examiners Amendment E-Mailed
Jun 18, 2024
Notification Of Examiners Amendment E-Mailed
Jun 18, 2024
Notification Of Examiners Amendment E-Mailed
Jun 18, 2024
Approved For Pub - Principal Register
Jun 18, 2024
Notification Of Examiners Amendment E-Mailed
Jun 18, 2024
Examiners Amendment E-Mailed
Jun 18, 2024
Examiners Amendment E-Mailed
Jun 18, 2024
Previous Allowance Count Withdrawn
Jun 18, 2024
Examiner's Amendment Entered
Jun 18, 2024
Examiners Amendment -Written
Jun 18, 2024
Examiner's Amendment Entered
Jun 18, 2024
Approved For Pub - Principal Register
Jun 18, 2024
Examiners Amendment -Written
Jun 18, 2024
Examiners Amendment E-Mailed
Jul 3, 2024
Notification Of Notice Of Publication E-Mailed
Jun 18, 2024
Examiners Amendment -Written

Trademark Alertz updated from USPTO on 2030-01-24